Evidence map›Paper›PMID 38500260›Full record

ArticleAngewandte Chemie (International ed. in English)2024

The Use of Xenonucleic Acids Significantly Reduces the In Vivo Drift of Electrochemical Aptamer-Based Sensors.

Kaylyn K Leung, Julian Gerson, Nicole Emmons, Jennifer M Heemstra, Tod E Kippin, Kevin W Plaxco

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Continuous, Week-Long, Seconds-ResolvedJournal of the American Chemical Society · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Wearable Electrochemical Biosensors for Advanced Healthcare Monitoring.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kaylyn K LeungDepartment of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, CA 93106, USA.
Julian GersonDepartment of Psychological and Brain Sciences, University of California, Santa Barbara.
Nicole EmmonsDepartment of Psychological and Brain Sciences, University of California, Santa Barbara.
Jennifer M HeemstraDepartment of Chemistry, Washington University in St. Louis, St. Louis, MO 63130, USA.
Tod E KippinDepartment of Psychological and Brain Sciences, University of California, Santa Barbara.
Kevin W PlaxcoDepartment of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, CA 93106, USA.ORCID 0000-0003-4772-8771

Funding

Bio-electrochemical detectors for in vivo continuous monitoringR01EB022015 · NIBIB · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI KIPPIN, TOD EDWARD, PLAXCO, KEVIN W · 2017 to 2025
$4.6M
Feedback controlled, ultra-high-precision drug deliveryR01AI145206 · NIAID · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI PLAXCO, KEVIN W · 2019 to 2023
$2.0M
Biostable nucleic acid aptamers for long-duration, in vivo molecular monitoringR21AI164483 · NIAID · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI PLAXCO, KEVIN W · 2021 to 2023
$443k
Foundation for the National Institutes of Health AI164483Foundation for the National Institutes of Health R01AI145206National Defense Science and Engineering Graduate National Defense Science and Engineering Graduate FellowshipNIAID NIH HHS R01 AI145206NIAID NIH HHS R21 AI164483NIBIB NIH HHS R01 EB022015Office of Naval Research N00014-20-1-2164Otis Williams Postdoctoral Fellowship Fund
6 · The paper itself

Abstract

Electrochemical aptamer-based sensors support the high-frequency, real-time monitoring of molecules-of-interest in vivo. Achieving this requires methods for correcting the sensor drift seen during in vivo placements. While this correction ensures EAB sensor measurements remain accurate, as drift progresses it reduces the signal-to-noise ratio and precision. Here, we show that enzymatic cleavage of the sensor's target-recognizing DNA aptamer is a major source of this signal loss. To demonstrate this, we deployed a tobramycin-detecting EAB sensor analog fabricated with the DNase-resistant "xenonucleic acid" 2'O-methyl-RNA in a live rat. In contrast to the sensor employing the equivalent DNA aptamer, the 2'O-methyl-RNA aptamer sensor lost very little signal and had improved signal-to-noise. We further characterized the EAB sensor drift using unstructured DNA or 2'O-methyl-RNA oligonucleotides. While the two devices drift similarly in vitro in whole blood, the in vivo drift of the 2'O-methyl-RNA-employing device is less compared to the DNA-employing device. Studies of the electron transfer kinetics suggested that the greater drift of the latter sensor arises due to enzymatic DNA degradation. These findings, coupled with advances in the selection of aptamers employing XNA, suggest a means of improving EAB sensor stability when they are used to perform molecular monitoring in the living body.

Indexed as

Aptamers, NucleotideBiosensing TechniquesElectrochemical TechniquesAnimalsRatsTobramycinAptamers, NucleotideTobramycinAptamer SensorElectrochemical Sensor DesignNon-natural OligonucleotidesSensor EngineeringXNA Sensor

Identifiers

PMID38500260
PMCPMC11821280

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.